Psoriasis and smoking: A systematic review and meta-analysis

British Journal of Dermatology

Volumn 170, Issue 2, 2014, Pages 304-314

  Armstrong, A W ^a   Harskamp, C T ^a   Dhillon, J S ^a   Armstrong, E J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; MALE; MIDDLE AGED; PSORIASIS; SMOKING; TOBACCO PRODUCTS;

EID: 84894264766     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.12670     Document Type: Review

References (53)

1. Gelfand JM, Weinstein R, Porter SB, et al,. Prevalence and treatment of psoriasis in the United Kingdom: a population-based study. Arch Dermatol 2005; 141: 1537-41.
2. Parisi R, Symmons DP, Griffiths CE, et al,. Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J Invest Dermatol 2013; 133: 377-85.
3. Armstrong AW, Lin SW, Chambers CJ, et al,. Psoriasis and hypertension severity: results from a case-control study. PLoS ONE 2011; 6: e18227.
4. Armstrong AW, Harskamp CT, Armstrong EJ,. The association between psoriasis and hypertension: a systematic review and meta-analysis of observational studies. J Hypertens 2012; 31: 433-42.
5. Armstrong AW, Harskamp CT, Armstrong EJ,. Psoriasis and the risk of diabetes mellitus: a systematic review and meta-analysis. JAMA Dermatol 2013; 149: 84-91.
6. Armstrong AW, Harskamp CT, Armstrong EJ,. The association between psoriasis and obesity: a systematic review and meta-analysis of observational studies. Nutr Diabetes 2012; 2: e54.
7. Armstrong AW, Harskamp CT, Armstrong EJ,. Psoriasis and metabolic syndrome: a systematic review and meta-analysis of observational studies. J Am Acad Dermatol 2013; 68: 654-62.
8. Ma C, Harskamp CT, Armstrong EJ, et al,. The association between psoriasis and dyslipidaemia: a systematic review. Br J Dermatol 2013; 168: 486-95.
9. Lakier JB,. Smoking and cardiovascular disease. Am J Med 1992; 93: 8S-12S.
10. Fielding JE,. Smoking: health effects and control (1). N Engl J Med 1985; 313: 491-8.
11. Giovino GA, Mirza SA, Samet JM, et al,. Tobacco use in 3 billion individuals from 16 countries: an analysis of nationally representative cross-sectional household surveys. Lancet 2012; 380: 668-79.
12. Fortes C, Mastroeni S, Leffondre K, et al,. Relationship between smoking and the clinical severity of psoriasis. Arch Dermatol 2005; 141: 1580-4.
13. Hagforsen E, Michaelsson K, Lundgren E, et al,. Women with palmoplantar pustulosis have disturbed calcium homeostasis and a high prevalence of diabetes mellitus and psychiatric disorders: a case-control study. Acta Derm Venereol 2005; 85: 225-32.
14. Li W, Han J, Qureshi AA,. Smoking and risk of incident psoriatic arthritis in US women. Ann Rheum Dis 2012; 71: 804-8.
15. Stroup DF, Berlin JA, Morton SC, et al,. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283: 2008-12.
16. Micha R, Wallace SK, Mozaffarian D,. Red and processed meat consumption and risk of incident coronary heart disease, stroke, and diabetes mellitus: a systematic review and meta-analysis. Circulation 2010; 121: 2271-83.
17. DerSimonian R, Laird N,. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-88.
18. Egger M, Davey Smith G, Schneider M, et al,. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-34.
19. Begg CB, Mazumdar M,. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50: 1088-101.
20. Mills CM, Srivastava ED, Harvey IM, et al,. Smoking habits in psoriasis: a case control study. Br J Dermatol 1992; 127: 18-21.
21. Al-Mutairi N, Al-Farag S, Al-Mutairi A, et al,. Comorbidities associated with psoriasis: an experience from the Middle East. J Dermatol 2010; 37: 146-55.
22. Armesto S, Santos-Juanes J, Galache-Osuna C, et al,. Psoriasis and type 2 diabetes risk among psoriatic patients in a Spanish population. Australas J Dermatol 2012; 53: 128-30.
23. Bo K, Thoresen M, Dalgard F,. Smokers report more psoriasis, but not atopic dermatitis or hand eczema: results from a Norwegian population survey among adults. Dermatology 2008; 216: 40-5.
24. Cohen AD, Gilutz H, Henkin Y, et al,. Psoriasis and the metabolic syndrome. Acta Derm Venereol 2007; 87: 506-9.
25. Driessen RJ, Boezeman JB, Van De Kerkhof PC, De Jong EM,. Cardiovascular risk factors in high-need psoriasis patients and its implications for biological therapies. J Dermatolog Treat 2009; 20: 42-7.
26. Gerdes S, Zahl VA, Weichenthal M, et al,. Smoking and alcohol intake in severely affected patients with psoriasis in Germany. Dermatology 2010; 220: 38-43.
27. Herron MD, Hinckley M, Hoffman MS, et al,. Impact of obesity and smoking on psoriasis presentation and management. Arch Dermatol 2005; 141: 1527-34.
28. Huerta C, Rivero E, Rodriguez LA,. Incidence and risk factors for psoriasis in the general population. Arch Dermatol 2007; 143: 1559-65.
29. Jankovic S, Raznatovic M, Marinkovic J, et al,. Risk factors for psoriasis: a case-control study. J Dermatol 2009; 36: 328-34.
30. Jin Y, Yang S, Zhang F, et al,. Combined effects of HLA-Cw6 and cigarette smoking in psoriasis vulgaris: a hospital-based case-control study in China. J Eur Acad Dermatol Venereol 2009; 23: 132-7.
31. Li W, Han J, Choi HK, Qureshi AA,. Smoking and risk of incident psoriasis among women and men in the United States: a combined analysis. Am J Epidemiol 2012; 175: 402-13.
32. Setty AR, Curhan G, Choi HK,. Smoking and the risk of psoriasis in women: Nurses' Health Study II. Am J Med 2007; 120: 953-9.
33. Naldi L, Chatenoud L, Linder D, et al,. Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: results from an Italian case-control study. J Invest Dermatol 2005; 125: 61-7.
34. Naldi L, Parazzini F, Brevi A, et al,. Family history, smoking habits, alcohol consumption and risk of psoriasis. Br J Dermatol 1992; 127: 212-17.
35. Naldi L, Peli L, Parazzini F,. Association of early-stage psoriasis with smoking and male alcohol consumption: evidence from an Italian case-control study. Arch Dermatol 1999; 135: 1479-84.
36. Neimann AL, Shin DB, Wang X, et al,. Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol 2006; 55: 829-35.
37. Poikolainen K, Reunala T, Karvonen J,. Smoking, alcohol and life events related to psoriasis among women. Br J Dermatol 1994; 130: 473-7.
38. Naldi L, Chatenoud L, Belloni A, et al,. Medical history, drug exposure and the risk of psoriasis. Evidence from an Italian case-control study. Dermatology 2008; 216: 125-30; discussion 130-2.
39. Shapiro J, Cohen AD, Weitzman D, et al,. Psoriasis and cardiovascular risk factors: a case-control study on inpatients comparing psoriasis to dermatitis. J Am Acad Dermatol 2012; 66: 252-8.
40. Sommer DM, Jenisch S, Suchan M, et al,. Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis. Arch Dermatol Res 2006; 298: 321-8.
41. Wolk K, Mallbris L, Larsson P, et al,. Excessive body weight and smoking associates with a high risk of onset of plaque psoriasis. Acta Derm Venereol 2009; 89: 492-7.
42. Wolkenstein P, Revuz J, Roujeau JC, et al,. Psoriasis in France and associated risk factors: results of a case-control study based on a large community survey. Dermatology 2009; 218: 103-9.
43. Xiao J, Chen LH, Tu YT, et al,. Prevalence of myocardial infarction in patients with psoriasis in central China. J Eur Acad Dermatol Venereol 2009; 23: 1311-15.
44. Zhang X, Wang H, Te-Shao H, et al,. Frequent use of tobacco and alcohol in Chinese psoriasis patients. Int J Dermatol 2002; 41: 659-62.
45. Zheng GY, Wei SC, Shi TL, et al,. Association between alcohol, smoking and HLA-DQA10201 genotype in psoriasis. Acta Biochim Biophys Sin (Shanghai) 2004; 36: 597-602.
46. Takahashi H, Takahashi I, Honma M, et al,. Prevalence of metabolic syndrome in Japanese psoriasis patients. J Dermatol Sci 2010; 57: 143-4.
47. Zhu KJ, He SM, Sun LD, et al,. Smoking and psoriasis: a meta-analysis of case-control studies. J Dermatol Sci 2011; 63: 126-8.
48. Yanbaeva DG, Dentener MA, Creutzberg EC, et al,. Systemic effects of smoking. Chest 2007; 131: 1557-66.
49. Pryor WA, Stone K,. Oxidants in cigarette smoke. Radicals, hydrogen peroxide, peroxynitrate, and peroxynitrite. Ann N Y Acad Sci 1993; 686: 12-27; discussion 27-8.
50. Emre S, Metin A, Demirseren DD, et al,. The relationship between oxidative stress, smoking and the clinical severity of psoriasis. J Eur Acad Dermatol Venereol 2012; 27: e370-5.
51. Armstrong AW, Armstrong EJ, Fuller EN, et al,. Smoking and pathogenesis of psoriasis: a review of oxidative, inflammatory and genetic mechanisms. Br J Dermatol 2011; 165: 1162-8.
52. Heeschen C, Jang JJ, Weis M, et al,. Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis. Nat Med 2001; 7: 833-9.
53. Yin XY, Cheng H, Wang WJ, et al,. TNIP1/ANXA6 and CSMD1 variants interacting with cigarette smoking, alcohol intake affect risk of psoriasis. J Dermatol Sci 2013; 70: 94-8.